Antiarrhythmic activity of buprenorphine against cardiac arrhythmia following coronary artery ligation.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D002047:Buprenorphine / Q000627:therapeutic use*; D003331:Coronary Vessels / Q000601:surgery*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D008026:Ligation; D008297:Male; D009019:Morphinans / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000150:complications; D009270:Naloxone / Q000494:pharmacology
D009019:Morphinans; D009270:Naloxone; D002047:Buprenorphine